Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03445962
Other study ID # 38RC17.161
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 15, 2017
Est. completion date July 11, 2019

Study information

Verified date April 2019
Source University Hospital, Grenoble
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The obstructive sleep apnea syndrome (OSAS) is frequently reported in subjects with trisomy 21. The consequences of this syndrome are expressed in various disorders such as cognitive and cardiovascular alterations. It is also reported a premature exhaustion with the achievement of various professional or recreational activities, as well as an increase in the frequency of daytime sleepiness. In trisomy 21, there are factors that are systematically associated with obstructive apnea. The identification of these factors would make it possible to diagnose OSAS earlier, under-diagnosed in the population with trisomy 21 even though these OSAS are associated with increased cardiovascular risks. The aim of this study is to identify the predictive factors associated with sleep apnea in the trisomy population in order to propose early detection. OSAS treatment in a young adult with Down syndrome could reduce physical fatigue apparition during various activities, reduce daytime sleepiness, and have a positive impact on physical fitness, and therefore more broadly on health.


Description:

The predictive factors for OSA that will be studied are: physical activity level, dentofacial disharmonies, blood parameters, motor disabilities, heart rate variability parameters measured during sleep and during autonomic nervous stimulation by orthostatic test. All these factors will be linked to the data obtained by: 1. polysomnography 2. by the joint use of seismocardiography OSAS lead to many associated disorders, which identified early can be better supported to limit the deleterious effects of this OSAS: (i) a sudden and repeated activation of the sympathetic nervous system triggered by sleep fragmentation (ii) intermittent hypoxia associated with OSAS may increase insulin resistance through the involvement of an inflammatory state and oxidative stress. (iii) a significant level of diurnal fatigue limiting activities, thus promoting a sedentary lifestyle and increasing cardiovascular risk factors. Several secondary objectives will therefore be studied: 1. Can OSAS be predicted by the existence of autonomic dysfunction? 2. Can OSAS be predicted by specific biological disturbances? 3. Can OSAS be predicted by the presence of a specific cranial structure? 4. Can OSAS be predicted by an insufficient level of physical activity? Finally does the use seismocardiography make it possible to identify quickly and early these risk factors linked to OSAS?


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date July 11, 2019
Est. primary completion date July 11, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Subjects with Down syndrome, able to practice physical activity all participants have received information all have signed the consent form Exclusion Criteria: - pregnant women - Pharmacological treatment altering autonomic nervous system (ANS) - Contra-indication to physical exercise, such as atlanto-axial instability

Study Design


Intervention

Diagnostic Test:
Assessment of OSAS predictive factors
All subjects of the two groups realized the same assessment: Anthropometric evaluation biological examination (hormonal, inflammatory and complete blood count, and lipidic profile) rest electrocardiogram motor assessment (strenght, flexibility and balance) actigraphy Autonomic nervous system assessment during sleep Autonomic nervous system assessment during head up tilt test before and after physical exercise maximal treadmill test (VO2 max measure) polysomnography seismocardiography questionnaires :sleep and physical activity

Locations

Country Name City State
France CHU Grenoble Alpes Échirolles

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

References & Publications (3)

Bricout VA, Guinot M, Faure P, Flore P, Eberhard Y, Garnier P, Juvin AF. Are hormonal responses to exercise in young men with Down's syndrome related to reduced endurance performance? J Neuroendocrinol. 2008 May;20(5):558-65. doi: 10.1111/j.1365-2826.2008.01695.x. Epub 2008 Mar 15. — View Citation

Flore P, Bricout VA, van Biesen D, Guinot M, Laporte F, Pépin JL, Eberhard Y, Favre-Juvin A, Wuyam B, van de Vliet P, Faure P. Oxidative stress and metabolism at rest and during exercise in persons with Down syndrome. Eur J Cardiovasc Prev Rehabil. 2008 Feb;15(1):35-42. doi: 10.1097/HJR.0b013e3282f2bff3. — View Citation

Leti T, Guinot M, Favre-Juvin A, Bricout VA. Difference of catecholamine responses to exercise in men with trisomy 21, with or without chronotropic incompetence. Physiol Behav. 2015 Apr 1;142:97-103. doi: 10.1016/j.physbeh.2015.02.007. Epub 2015 Feb 4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Identification of predictive factors associated to obstructive sleep apnea syndrome in DS subjects OSAS will be diagnosed with polysomnography and seismocardiography. AHI threshold will be 15 to diagnose an OSAS (score). 4 months
Secondary dysautonomia role on OSAS in DS Cardiac response during exercise (existence of chronotropic incompetence
%HR(reserve)lower than 80%)
1 day
Secondary Investigation of autonomic nervous system spectral variations of blood pressure and heart rate variability during head-up tilt test : (spectral density in ms² and normalized units) 1 day
Secondary Oxygenation and dysautonomia Cerebral and peripheral oxygenation parameters measured with near-infrared spectroscopy during head-up tilt test (delta Hbtot between supine and head up tilt positions)
- Cardiac response during exercise (existence of chronotropic incompetence)
1 day
Secondary Investigation of dysautonomia during sleep spectral variations of heart rate variability (spectral density in ms² and normalized units) 3 nignts
Secondary Biological profile Disorders in blood parameters will be assessed by different inflammatory, corticotropic, thyroid and glycemic values in comparison with reference values. 1 day
Secondary anthropometric characteristics role on OSAS in DS Existence of morphologic specificities will be investigated:
Craniofacial abnormalities with orthopantomogram (degree)
1 day
Secondary Metabolic syndrome Existence of morphologic specificities will be investigated:
Neck, waist and hips circumferences (cm)
1 day
Secondary morphologic parameters Existence of morphologic specificities will be investigated:
Body fat composition (%)
1 day
Secondary Quantification of physical activity Physical activity level will be assessed with actigraphy (min or h per day) 15 days
Secondary Motor skills motor capacities : strength (explosive leg power (cm) and handgrip measure), flexibility (cm), balance (cm) 15 days
Secondary questionnaire of physical activity G- PAQ and parental perceptions of physical activity (score) 15 days
Secondary Sleep questionnaire Epworth and Pittsburg questionnaire (score) 15 days
See also
  Status Clinical Trial Phase
Terminated NCT03605329 - Evaluation of the Severity of Cardiovascular Autonomic Neuropathy in Type 1 Diabetic Patients With OSAS N/A
Completed NCT04912635 - Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo N/A
Not yet recruiting NCT05939934 - Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal N/A
Enrolling by invitation NCT02290236 - Monitored Saturation Post-ICU N/A
Completed NCT02088723 - Testing the Elevation as Sleep Apnea Treatment N/A
Terminated NCT02269774 - Origin of Premature Atrial Beats Induced by Simulated Obstructive Sleep Apnea N/A
Completed NCT02261857 - 3D-Printed CPAP Masks for Children With Obstructive Sleep Apnea Early Phase 1
Completed NCT01181570 - Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea Phase 4
Completed NCT01943708 - Novel Auto-continuous Positive Airway Pressure (CPAP) Validation Phase 3
Completed NCT00273754 - The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA). Phase 2
Recruiting NCT02166879 - Undetected Sleep Apnea in the Postanesthesia Acute Care Unit (PACU)
Recruiting NCT04963192 - Integrated Management of Chronic Respiratory Diseases N/A
Completed NCT04846400 - Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia N/A
Completed NCT05056766 - How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement
Recruiting NCT04314492 - Intracapsular Tonsillectomy in the Treatment of Obstructive Sleep Apnea in Adults N/A
Completed NCT05175287 - OSA (oRisk of Obstructive Sleep Apnea and Traffic Accidents Among Bus Drivers in Ecuador: is There a Significant Association
Active, not recruiting NCT03431038 - Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH N/A
Enrolling by invitation NCT03075787 - Cardiovascular Variability and Heart Rate Response Associated With Obstructive Sleep Apnea N/A
Completed NCT03300037 - HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor N/A
Recruiting NCT06097949 - AcuPebble to Remotely Monitor Patients With OSA on CPAP Therapy